Skip to main content
. Author manuscript; available in PMC: 2010 Oct 20.
Published in final edited form as: Alcohol Clin Exp Res. 2009 Nov 24;34(2):375–381. doi: 10.1111/j.1530-0277.2009.01099.x

Table 4.

Brain Krebs Cycle and Coenzyme A (CoA) Intermediates

Saline Ethanol Acetate
Citrate 0.286 ± 0.034 0.268 ± 0.023b 0.373 ± 0.047
Isocitrate 0.022 ± 0.0005 0.023 ± 0.001 0.022 ± 0.0002
α-Ketoglutarate 0.170 ± 0.004 0.170 ± 0.005 0.201 ± 0.007a,b
Succinyl CoA (μM) 3.36 ± 0.47 4.15 ± 0.41 3.54 ± 0.24
Succinate 0.160 ± 0.007 0.145 ± 0.010 0.158 ± 0.008
Fumarate 0.128 ± 0.010 0.133 ± 0.010 0.169 ± 0.013a
l-Malate 0.266 ± 0.015 0.252 ± 0.024 0.275 ± 0.034
Calc oxaloacetate 0.0068 ± 0.0002 0.0063 ± 0.0005 0.0089 ± 0.0008a,b
Acetyl CoA (μM) 3.40 ± 1.32 3.35 ± 0.31 2.78 ± 0.21
Malonyl CoA (μM) 2.05 ± 0.33 3.15 ± 0.31a 2.32 ± 0.15

Animals infused with solutions of phosphate buffered saline (PBS) (n = 5), 4 M ethanol in PBS (n = 8), or 2 M sodium acetate in PBS (n = 6). Values are means in μmole/g wet weight ± SEM. CoA’s are given in nmol/g wet weight.

a

p < 0.05 between infused and saline group.

b

p < 0.05 between ethanol-infused and acetate-infused, paired t-test with Bonferroni adjustment for multiple group comparisons.